Alternate Splicing of Interleukin-1 Receptor Type II (IL1R2) In Vitro Correlates with Clinical Glucocorticoid Responsiveness in Patients with AIED
Andrea Vambutas, James DeVoti, Elliot Goldofsky et al. · 2009
Read Alternate Splicing of Interleukin-1 Receptor Type II (IL1R2) In Vitro Correlates with Clinical Glucocorticoid Responsiveness in Patients with AIED by Andrea Vambutas, James DeVoti, Elliot Goldofsky et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005293.txt.
Description
Autoimmune inner ear disease causes hearing loss and has no definitive lab test. All suspected patients get steroid drugs during attacks, yet only about half respond at first. Vambutas and colleagues looked for a predictor of that response in PLOS ONE in 2009.
Alternative splicing of the IL1R2 gene, measured in lab tests, correlated with how patients responded to glucocorticoids. A splicing pattern that forecasts response could spare non-responders months of useless steroids. It would also give this poorly defined disease its first practical test. Hearing loss in this disease can come on fast, and each week on the wrong drug is a week of loss that may not come back. So a guide test is worth a great deal.
Catalog record
| CREATOR | Andrea Vambutas, James DeVoti, Elliot Goldofsky et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005293